SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-13-011737
Filing Date
2013-09-09
Accepted
2013-09-09 07:02:25
Documents
4
Period of Report
2013-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pdli20130906_8k.htm 8-K 28585
2 EXHIBIT 99.1 ex99-1.htm EX-99 26664
3 EXHIBIT 99.2 ex99-2.htm EX-99 992724
4 logo.jpg GRAPHIC 9126
  Complete submission text file 0001437749-13-011737.txt   1061853
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 131084234
SIC: 2836 Biological Products, (No Diagnostic Substances)